The recently released White House Office of Science and Technology Policy (OSTP) report, Bold Goals for U.S. Biotechnology and Biomanufacturing, highlights where insights provided by human genetics and genomics are fundamental for the health biotechnology ecosystem and are critical components of the bioeconomy. This report comes after OSTP solicited public input in a Request for... Read More
ASHG recently responded to a select number of questions in a Request for Information (RFI) from the White House Office of Science and Technology Policy (OSTP) on the National Biotechnology and Biomanufacturing Initiative. OSTP released this RFI to seek public input on how advances in biotechnology and biomanufacturing can help support a strong bioeconomy. The insights... Read More
The Access to Genetic Counselor Services Act was introduced in the U.S. House of Representatives (H.R. 2144) and the U.S. Senate (S. 1450) to recognize certified genetic counselors as healthcare providers and authorize the Centers for Medicare and Medicaid Services (CMS) to reimburse genetic counselors directly for the genetic counseling services they provide to Medicare... Read More
Scientists are in the unique position to directly convey the benefits of human genetics and genomics research to policymakers. It is critical that we communicate the benefits of human genetics and genomics research to Congress because decisions happen on the Hill that affect research and the use of genetics-based technologies – with or without our... Read More
Applications for the 2026-2027 class have closed. Human genetics and genomics are advancing at an extraordinary pace, and the field needs informed, compelling voices who can help policymakers understand and support our work. The ACGT Program was created to empower emerging scientists with the tools to contribute to the conversation, equipping them with the policy... Read More